Literature DB >> 12475102

Interatrial transseptal electrical conduction: comparison of patients with atrial fibrillation and normal controls.

David O'Donnell1, John P Bourke, Steve S Furniss.   

Abstract

INTRODUCTION: This study analyzed the electrophysiologic properties of interatrial transseptal electrical conduction at Bachmann's bundle and the ostium of the coronary sinus (CS os) in response to pulmonary vein (PV) stimuli, which mimicked spontaneous ectopy. METHODS AND
RESULTS: Forty patients with atrial fibrillation (AF) referred for ablation (15 persistent AF and 25 paroxysmal AF) and 15 control patients were enrolled in the study. During decremental extra-stimulus pacing from the PVs, right atrial activation was analyzed using noncontact mapping and multipolar catheters. The refractory periods and conduction times were calculated for Bachmann's bundle, CS os, and left atrium. The dispersion of refractoriness was calculated as the difference between the refractory periods of Bachmann's bundle and the CS os. The refractory period at Bachmann's bundle was 244 msec in the persistent AF group, 213 msec in the paroxysmal AF group, and 199 msec for controls. The refractory period at the CS os was 220 msec in the persistent AF group, 201 msec in the paroxysmal AF group, and 193 msec for controls. The dispersion of refractoriness was 54 msec in the persistent AF group; this was significantly greater than in paroxysmal AF at 32 msec (P < 0.05) and controls at 13 msec (P < 0.01). During decremental pacing, lengthening of conduction times at both Bachmann's bundle and the CS os were significantly greater in the persistent AF group compared with paroxysmal AF or control groups. A higher dispersion of refractoriness was associated with a higher incidence of inducible AF and a lower rate of ablation success.
CONCLUSION: There are differences between the left to right interatrial electrical connections between patients with persistent AF, paroxysmal AF and controls.

Entities:  

Mesh:

Year:  2002        PMID: 12475102     DOI: 10.1046/j.1540-8167.2002.01111.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

Review 1.  Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance.

Authors:  Nicolas Johner; Mehdi Namdar; Dipen C Shah
Journal:  J Interv Card Electrophysiol       Date:  2018-08-20       Impact factor: 1.900

2.  Electrophysiological models for the heterogeneous canine atria: computational platform for studying rapid atrial arrhythmias.

Authors:  Oleg V Aslanidi; Timothy D Butters; Christopher X Ren; Gareth Ryecroft; Henggui Zhang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

3.  Interatrial right-to-left conduction in patients with paroxysmal atrial fibrillation.

Authors:  Jari M Tapanainen; Raija Jurkko; Fredrik Holmqvist; Daniela Husser; Ole Kongstad; Markku Mäkijärvi; Lauri Toivonen; Pyotr G Platonov
Journal:  J Interv Card Electrophysiol       Date:  2009-03-13       Impact factor: 1.900

4.  Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population.

Authors:  Fredrik Holmqvist; Pyotr G Platonov; Jonas Carlson; Rasmus Havmöller; Johan E P Waktare; William J McKenna; S Bertil Olsson; Carl J Meurling
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

5.  Application of micro-computed tomography with iodine staining to cardiac imaging, segmentation, and computational model development.

Authors:  Oleg V Aslanidi; Theodora Nikolaidou; Jichao Zhao; Bruce H Smaill; Stephen H Gilbert; Arun V Holden; Tristan Lowe; Philip J Withers; Robert S Stephenson; Jonathan C Jarvis; Jules C Hancox; Mark R Boyett; Henggui Zhang
Journal:  IEEE Trans Med Imaging       Date:  2012-07-17       Impact factor: 10.048

6.  Conduction Disorders during Sinus Rhythm in Relation to Atrial Fibrillation Persistence.

Authors:  Willemijn F B van der Does; Annejet Heida; Lisette J M E van der Does; Ad J J C Bogers; Natasja M S de Groot
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.